- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01907620
Circulating Oxidative Stress and Gestational Hypertension. Study of the Evolution of Free-radical Markers of Oxidative Stress From Before to After Childbirth in Two Groups of Women: Normal Pregnancy and Pre-eclampsia.
The aim of this study is to explore a mechanism that could potentially explain why women with a pregnancy complicated by pre-eclampsia are described as having an increased risk of cardiovascular disease later in life.
If the hypothesis of this study turns out to be true, that is to say that women with pre-eclampsia have a higher level of oxidative stress than women with a normal pregnancy and that this difference persists after the delivery (6 months), a controlled randomized interventional study aiming to evaluate either therapeutic supplementation with antioxidant vitamins (Vit C and E) or modifications in diet could be envisaged.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Dijon, Frankrike, 21079
- CHU de DIJON
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients who have provided written informed consent
- Patients covered by a Health Insurance scheme
- Age > 18 years
- Normal pregnancy
- or pre-eclampsia defined according to the following classical criteria: (i) de novo hypertension defined by arterial blood pressure of at least 140 mm Hg (systolic) or at least 90 mm Hg (diastolic) confirmed by at least two measurements separated by at least 4-6 h, occurring after the 20th week of gestation in a women known beforehand to have a normal blood pressure, (ii) proteinuria defined by urinary excretion of at least 300 mg of protein per 24 h. If 24-hour urine is not available, proteinuria is defined as a concentration of urinary protein of 300 mg/L or more (or >1 + on the urinary dip) in at least two samples of urine taken randomly, but at an interval of at least 4-6 h [7]. Pre-eclampsia is defined as severe if: persistent systolic BP > 170 mm Hg and/or diastolic BP > 110 mm Hg, and/or diuresis < 30 ml/hour, and/or at least 2 of the following signs (headache, phosphenes, epigastric pain or vomiting, pyramidal-type patellar reflexes, papilledema, hepatic pain, thrombopenia < 100x106 /l, ALT AST > 70 UI/l and or hemolysis manifesting as haptoglobin < 0.06 g/l, or a fall in LDH or the presence of schistocytes, the latter three signs define the HELLP syndrome) and/or seizures.
- Term> 26 SA.
Exclusion Criteria:
- Refusal to provide consent
- Context of patent infection.
- Premature rupture of the fetal membranes.
- preexisting or gestational diabetes.
- Vasculoplacental diseases other than pre-eclampsia: placental abruption or infarction, intrauterine growth retardation of in utero fetal death not occurring in a context of pre-eclampsia.
- Chronic or gestational AHT not meeting the criteria for pre-eclampsia.
- Twin/multiple pregnancies
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Trippel
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Normal pregnancy
women pregnant
|
|
|
Annen: pregnancy complicated by pre-eclampsia
women with pregnancy complicated by pre-eclampsia
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
quantification of radical species
Tidsramme: baseline
|
baseline
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Sagot PHRC IR 2007
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Normal graviditet
-
Assiut UniversityHar ikke rekruttert ennåNormal arbeidskraft
-
Massachusetts General HospitalRekrutteringNormal fysiologiForente stater
-
National Institute of Environmental Health Sciences...Rekruttering
-
Assistance Publique - Hôpitaux de ParisURC Necker Cochin, FranceRekrutteringNormal graviditetFrankrike
-
National Institute of Neurological Disorders and...RekrutteringNormal fysiologiForente stater
-
National Institute of Neurological Disorders and...FullførtNormal fysiologiForente stater
-
National Institute of Neurological Disorders and...FullførtNormal fysiologiForente stater
-
National Institute of Neurological Disorders and...Fullført
-
Tetraphase Pharmaceuticals, Inc.Department of Health and Human ServicesFullførtNormal medikamenttoleranseForente stater
-
National Center for Complementary and Integrative...Fullført
Kliniske studier på blodprøve
-
Hillel Yaffe Medical CenterUkjent
-
Eastern Mediterranean UniversityFullførtMuskelstyrke | Muskelhypertrofi | SportsytelseKypros
-
ExThera Medical Europe BVExThera Medical Corporation; Vivantes Clinic NeuköllnRekrutteringBlodstrømsinfeksjonFrankrike, Tyskland, Nederland, Østerrike, Belgia, Italia, Polen, Spania, Storbritannia
-
Ascensia Diabetes CareFullført
-
Stanford UniversityRekrutteringVaskulære sykdommer | Slag | Hypertensjon | TIAForente stater
-
InSightecRekrutteringAlzheimers sykdomForente stater
-
InSightecFocused Ultrasound FoundationFullført
-
Mayo ClinicFullført
-
Lauren EricksonAmerican College of Sports MedicineFullførtPatellofemoralt syndromForente stater